Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Venmax Drugs and Pharmaceuticals has informed that the Board of Directors in their Meeting held on Tuesday, September 10, 2024 have approved the resignation of A. Ramakrishnaiah from the position of Independent Director of the Company with effect from September 10, 2024. Consequent to his resignation, he shall also cease to be Member of the Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee of the Company. The Resignation Letter received from A. Ramakrishnaiah is enclosed. The information in regard to the abovementioned change in the Board, in terms of Regulation 30 read with the Schedule III -Para A(7B) of Part-A of the Listing Regulations (as applicable) and SEBI Circular CIR/CFD/CMD/4/2015 dated 9th September, 2015 is provided in Annexure -A.
The above information is a part of company’s filings submitted to BSE.
